Twenty LEAD Coalition member and partner organizations have joined in a public comment to the Food and Drug Administration regarding implementation of PDUFA V patient-focused drug development activities.
Twenty LEAD Member and Partner Organizations Urge the Food and Drug Administration to Prioritize Alzheimer’s Disease and Related Disorders
